Bicycle Therapeutics PLC (BCYC)
22.16
-0.20
(-0.92%)
USD |
NASDAQ |
May 16, 16:00
22.16
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics Cash from Investing (TTM): -0.842M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -0.842M |
December 31, 2023 | -2.929M |
September 30, 2023 | -4.326M |
June 30, 2023 | -6.808M |
March 31, 2023 | -16.33M |
December 31, 2022 | -18.99M |
September 30, 2022 | -18.61M |
June 30, 2022 | -15.79M |
March 31, 2022 | -6.163M |
December 31, 2021 | -2.03M |
September 30, 2021 | -1.447M |
Date | Value |
---|---|
June 30, 2021 | -1.373M |
March 31, 2021 | -1.503M |
December 31, 2020 | -1.20M |
September 30, 2020 | -1.107M |
June 30, 2020 | -1.295M |
March 31, 2020 | -1.457M |
December 31, 2019 | -1.555M |
September 30, 2019 | -1.574M |
June 30, 2019 | -1.417M |
March 31, 2019 | -1.34M |
December 31, 2018 | -1.186M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-18.99M
Minimum
Dec 2022
-0.842M
Maximum
Mar 2024
-5.337M
Average
-1.564M
Median
Cash from Investing (TTM) Benchmarks
Biodexa Pharmaceuticals Plc | -0.3289M |
NuCana PLC | 3.594M |
TC BioPharm (Holdings) PLC | -0.2614M |
Adaptimmune Therapeutics PLC | 176.54M |
Verona Pharma PLC | -0.016M |